A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Part of paid clinical trials in Sheffield, Alabama.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT04537923
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tirzepatide — DRUGAdministered SC
- Insulin Lispro (U100) — DRUGAdministered SC
Study Details
The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to insulin lispro (U100) three times a day in participants with type 2 diabetes that are already on insulin glargine (U100), with or without metformin.
Key Dates
- Start date
- Oct 19, 2020
- Status verified
- Oct 2023
- Primary completion
- Oct 11, 2022
- Completion
- Nov 1, 2022
Study Design
- Enrollment
- 1,428 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 5 mg Tirzepatide5 milligrams (mg) tirzepatide administered subcutaneously (SC) once a week.
- Experimental: 10 mg Tirzepatide10 mg tirzepatide administered SC once a week.
- Experimental: 15 mg Tirzepatide15 mg tirzepatide administered SC once a week.
- Active Comparator: Insulin LisproInsulin lispro 100 units per milliliter (U100) administered SC three times a day.
Primary Outcome Measure
Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses of Tirzepatide 5 mg, 10 mg and 15 mg) [ Time Frame: Baseline, Week 52 ]
Locations (40)
Find similar trials in Sheffield, AL
By condition
By specialty
By research site
Syed Research Consultants Llc· Sheffield, ALValley Research· Fresno, CANational Research Institute - Huntington Park· Huntington Park, CANational Research Institute - Huntington Park· Los Angeles, CAValley Clinical Trials, Inc.· Northridge, CANational Research Institute - Huntington Park· Panorama City, CA
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Sleep and Glycemic Control in Type 2 Diabetes AdolescentsRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)Recruiting · Children's Hospital Los Angeles · Los Angeles, California